Embryotoxicity of regressing corpora lutea in ewes.
Experiments were performed to test the null hypotheses that embryonic survival is not affected by the presence of regressing corpora lutea in progestogen-supplemented ewes, and that the embryotoxic effects of regressing corpora lutea do not act locally on embryos in the uterine horn adjacent to the regressing corpora lutea. In Expt 1, laparotomies were performed on day 4 after mating, and progestogen supplementation was initiated and continued until pregnancy was diagnosed by ultrasonography on day 25. On day 4 after mating, ewes were lutectomized (n = 17) or sham lutectomized (n = 15), and injected (i.m.) with 5 mg PGF2alpha at 8 h intervals for 2 or 3 days. Controls (n = 14) were sham lutectomized and injected with saline as described above. Pregnancy rates did not differ in ewes treated with PGF2alpha for 2 rather than 3 days. Pregnancy rates were lower in ewes treated with PGF 2a compared with controls (P < 0.01). In ewes treated with PGF2alpha, lutectomy resulted in an increase in pregnancy rates (59%) compared with ewes subjected to sham lutectomy (33%; P < 0.05). In Expt 2, progestogen supplementation was initiated in the morning of day 4 after mating and continued until pregnancy diagnosis on day 25. In the afternoon of day 4, one ovary selected at random was lutectomized in ewes (n = 34) with at least one corpus luteum on each ovary, and the uterine horns were isolated by ligation to impede intraluminal transfer of luteal or uterine products that might initiate embryonic death. On days 5-8 after mating, equal numbers of ewes were injected i.m. with either saline or 5 mg PGF2alpha at 8 h intervals. Pregnancy rates did not differ between isolated uterine horns contralateral and ipsilateral to the regressing corpus luteum; however, pregnancy rates were lower in PGF2alpha-treated ewes than in saline-treated ewes (34 and 77%; P < 0.05). In conclusion, regressing corpora lutea exert an embryotoxic effect; however, there is no evidence that this effect occurs through systemic pathways.
Costine
B A
BA
Division of Animal and Veterinary Sciences, West Virginia University, Morgantown,WV 26506-6108, USA.
Sayre
B L
BL
Inskeep
E K
EK
D000818:Animals; D003338:Corpus Luteum / Q000000981:diagnostic imaging / Q000378:metabolism*; D015237:Dinoprost / Q000494:pharmacology; D005260:Female; D005313:Fetal Death; D003425:Flurogestone Acetate / Q000494:pharmacology; D003341:Luteolysis; D011247:Pregnancy; D045167:Progesterone Congeners / Q000494:pharmacology; D011897:Random Allocation; D012756:Sheep / Q000378:metabolism*; D014463:Ultrasonography
D045167:Progesterone Congeners; D015237:Dinoprost; D003425:Flurogestone Acetate